You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

focal onset,lacosamide,CEA,Real-world,first add on

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epilepsy, Focal-Onset Seizure Trial in China (lacosamide)

Not yet recruiting
  • Epilepsy
  • Focal-Onset Seizure
  • Beijing, Beijing, China
  • +18 more
Feb 2, 2021

Adjunctive Anti-seizure Medication Real World Evidence Study

Recruiting
  • Epilepsy
  • ASM as adjunctive therapy
  • Milan, Italy
    Fondazione IRCCS Istituto Neurologico "Carlo Besta" U.O. Epilett
May 17, 2023

CENOBAMATE as Adjunctive Treatment in Patients Suffering From

Recruiting
  • Focal Onset Seizure
  • Epilepsy
    • Bron, France
    • +22 more
    Mar 6, 2023

    ive Briviact is as add-on Treatment for Epilepsy With Partial

    Completed
    Has Results
    • Epilepsy With POS With or Without Secondary Generalization
      • Aarhus, Denmark
      • +43 more
      Jul 12, 2021

      Acute Ischemic Stroke in China

      Recruiting
      • Ischemic Stroke
      • Shanghai, China
        Xin Chen
      Oct 9, 2023

      Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous

      Recruiting
      • Breast Cancer
      • +4 more
      • Web bases survey
      • Canton, Ohio
        Cleveland Clinic Mercy Hospital
      Aug 2, 2023

      A Study of Rituximab in Frontline Therapy for Glomerulonephritis

      Recruiting
      • Glomerulonephritis
        • Shanghai, China
        • +4 more
        Feb 27, 2023

        Pompe Disease Trial in New York, Fairfax (biological, drug, other)

        Not yet recruiting
        • Pompe Disease
        • Cipaglucosidase alfa
        • +3 more
        • New York, New York
        • +1 more
        Nov 2, 2023

        Focal Onset Seizures Trial (EQU-001, Matching Placebo)

        Not yet recruiting
        • Focal Onset Seizures
        • (no location specified)
        Jul 26, 2022

        Elderly Acute Ischaemic Stroke (AIS) Patients

        Completed
        • Stroke
        • Shanghai, China
          Boehringer Ingelheim (China) Investment Co., ltd.
        Dec 23, 2022

        Ovarian Tumors Trial in Nanjing (Niraparib)

        Completed
        • Ovarian Neoplasms
        • Nanjing, China
          Zhongda hospital
        Feb 17, 2023

        ASCT Versus Chemotherapy as First-Line Consolidation Therapy

        Completed
        • T-cell Lymphoma Adults
        • consolidation with ASCT
        • (no location specified)
        Nov 25, 2023

        da Vinci SP Surgical System for Single-Port Gynecological

        Recruiting
        • Gynecological Surgeries
        • da Vinci SP Surgical System
        • Shanghai, Shanghai, China
          Shanghai JiaoTong University School of Medicine affliated Ruijin
        Oct 8, 2023

        A Multicountry, Multicentre, Non-interventional, Retrospective

        Recruiting
        • Carcinoma, Non-Small-Cell Lung
          • Kuwait, Kuwait
            Kuwait Cancer Control Center
          Sep 13, 2023

          Recombinant Tissue Plasminogen Activator Treated Chinese Acute

          Completed
          • Stroke
          • Shanghai, China
            Boehringer Ingelheim (China) Investment Co., ltd.
          Dec 22, 2022

          Evaluate the Use and Effectiveness of Doptelet® in ITP

          Recruiting
          • Immune Thrombocytopenia
          • ITP
          • Zagreb, Croatia
          • +59 more
          Jan 12, 2023

          da Vinci SP Surgical System for Single-Port Colorectal

          Recruiting
          • Single-Port Colorectal Surgeries
          • procedure
          • Shanghai, Shanghai, China
            Ruijin Hospital
          Nov 15, 2023

          Partial Epilepsy Trial in Phoenix, Bethesda, Memphis (Xcopri)

          Active, not recruiting
          • Partial Epilepsy
          • Phoenix, Arizona
          • +4 more
          Dec 20, 2022

          Real-world Study Optimizing Nucleotide-analogues

          Recruiting
          • Hepatitis B, Chronic
          • Hefei, Anhui, China
          • +43 more
          Jul 7, 2023

          Inetetamab Combined With Pyrotinib and Vinorelbine as First-line

          Recruiting
          • Breast Neoplasms
          • Nanjing, Jiangsu, China
            Jiangsu Provincial People's Hospital
          Mar 16, 2023

          Palbociclib in Canadian Breast Cancer That Has Spread to Other

          Not yet recruiting
          • Breast Cancer
          • (no location specified)
          Aug 18, 2023

          HER2-overexpressed Advanced Solid Tumors After Progression of

          Not yet recruiting
          • HER2
          • +3 more
          • Disitamab Vedotin
          • Beijing, Beijing, China
            Beijing Cancer Hospital
          Dec 14, 2022

          Study Assessing Safety and Efficacy of Nerivio for Migraine

          Recruiting
          • Migraine
          • Nerivio
          • Bridgewater, New Jersey
            Theranica Inc USA
          Jul 10, 2023

          Emulation of KEYNOTE-189 Trial Using Electronic Health Records

          Active, not recruiting
          • Non-small Cell Lung Cancer
          • Metastatic Lung Cancer
          • Boston, Massachusetts
            Aetion
          Jun 14, 2023

          ADHD Trial in Boston (EndeavorOTC)

          Enrolling by invitation
          • ADHD
          • EndeavorOTC
          • Boston, Massachusetts
            Akili Interactive Labs, Inc.
          Oct 27, 2023